Assembly Biosciences Inc (ASMB) — Cash Flow Reinvestment Rate
Assembly Biosciences Inc (ASMB) has a Cash Flow Reinvestment Rate of 1.49x as of December 2025, reinvesting $21.27 Million (capex $24.00K plus investments $21.25 Million) from operating cash flow of $14.24 Million. See ASMB free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Assembly Biosciences Inc Cash Flow Reinvestment Rate (2017–2023)
Historical reinvestment intensity for Assembly Biosciences Inc across 2 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Assembly Biosciences Inc.
Annual Cash Flow Reinvestment Rate for Assembly Biosciences Inc (2017–2023)
Year-by-year capital reinvestment analysis for Assembly Biosciences Inc. See Assembly Biosciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 1.64x | $37.33 Million | $22.74 Million | $255.00K | ▼ -80.5% |
| 2017 | 8.41x | $15.64 Million | $1.86 Million | $864.56K | — |